Table 5.
Impact of risk assessment tool-informed strategies on TBI diagnosis and TST requirements in our sample
| Scenario | Measures stratified by age (n = total in sample) | Standard of care,* n (% of sample) | Application of 2-item score,† n (% of sample) | Application of 4-item score,‡ n (% of sample) |
|---|---|---|---|---|
| TSTs administered | Younger than 5 (n = 2,182) | 96 (4) | 1,115 (51) | 136 (6) |
| 5–15 years (n = 3,294) | 231 (7) | 1,782 (54) | 1,782 (54) | |
| Total (n = 5,476) | 327 (6) | 2,897 (53) | 1,918 (35) | |
| TSTs administered in children free of TBI | Younger than 5 (n = 2079) | 78 (4) | 1,036 (50) | 109 (5) |
| 5–15 years (n = 3,043) | 231 (8) | 1,576 (52) | 1,576 (52) | |
| Total (n = 5,122) | 309 (6) | 2,612 (51) | 1,685 (33) | |
| TSTs averted in children free of TBI | Younger than 5 (n = 2079) | 2,001 (96) | 1,043 (50) | 1,970 (95) |
| 5–15 years (n = 3,043) | 2,812 (92) | 1,467 (48) | 1,467 (48) | |
| Total (n = 5,122) | 4,813 (94) | 2,510 (49) | 3,437 (67) |
TBI = tuberculosis infection; TST = tuberculin skin test.
*
Based on Philippine national guidelines.20
†
Children with a score of one or more are considered screen positive.
‡
Children with a score of two or more are considered screen positive.